Related Experiment Videos

Insulin-like growth factor I levels in healthy children

P E Clayton1, C M Hall

  • 1University of Manchester, Endocrine Science Research Group, Manchester, UK. peter.clayton@man.ac.uk

Hormone Research
|March 12, 2005
PubMed

Insights

Accurate measurement of insulin-like growth factor I (IGF-I) is crucial for diagnosing growth hormone (GH) deficiency in children and monitoring therapy. Reliable normative data and assay understanding are essential for interpreting IGF-I levels effectively.

Area of Science:

  • Pediatric Endocrinology
  • Biochemical Diagnostics
  • Growth Hormone Axis

Background:

  • Insulin-like growth factor I (IGF-I) measurement is vital for assessing growth hormone (GH) deficiency in children.
  • Monitoring GH replacement therapy efficacy relies on accurate IGF-I level assessment.
  • Robust normative data are necessary for standardizing IGF-I values and tracking changes over time.

Purpose of the Study:

  • To highlight the importance of reliable normative data for IGF-I measurements in pediatric growth assessment.
  • To emphasize the need for clinicians to understand the performance and limitations of IGF-I assays.
  • To underscore that IGF-I measurement is a component of diagnosis, not the sole determinant.

Main Methods:

  • Review of factors influencing IGF-I levels in healthy children (age, gender, puberty, etc.).
  • Discussion on the necessity of large-scale data collection from healthy pediatric populations.
  • Emphasis on the limited availability of external quality assurance schemes and international standards for IGF-I.

Main Results:

  • IGF-I levels are influenced by numerous physiological and environmental factors in children.
  • The generation of comprehensive normative data requires extensive sample collection.
  • Variability in assay performance and lack of widespread standardization pose challenges.

Conclusions:

  • Clinicians must be aware of assay limitations and data sources for accurate IGF-I interpretation.
  • Understanding individual tissue sensitivity to IGF-I is crucial.
  • IGF-I measurement, while important, has inherent limitations within the broader diagnostic context.

Related Concept Videos

Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...